Mepolizumab attenuates ILC2s proliferation and activity in adults with severe eosinophilic asthma.

Brusselle, Guy; Riemann, Sebastian; Maes, Tania

Brusselle, Guy; Riemann, Sebastian; Maes, Tania.

Brusselle G; Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
Riemann S; Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
Maes T; Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.

Respirology ; 28(8): 696-698, 2023 08.

Article en En | MEDLINE | ID: mdl-37164907

Asunto(s)

Antiasmáticos; Asma; Eosinofilia Pulmonar; Humanos; Adulto; Inmunidad Innata; Linfocitos; Asma/tratamiento farmacológico; Eosinofilia Pulmonar/tratamiento farmacológico; Proliferación Celular; Antiasmáticos/farmacología; Antiasmáticos/uso terapéutico; Eosinófilos

Palabras clave

asthma; clinical allergy and immunology; cytokine; eosinophil; inflammation

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Eosinofilia Pulmonar / Asma / Antiasmáticos Límite: Adult / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google